Becton, Dickinson and Co. | BDX - Pre Tax Profit

Stock Price
149.52
Daily Change
-0.70 -0.47%
Monthly
-3.34%
Yearly
-27.57%
Q2 Forecast
148.88

Becton, Dickinson and Co. reported $393M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Agilent USD 442M 1000K Sep/2025
Align Technology USD 176.6M 81.86M Dec/2025
AngioDynamics USD -6.4M 5.03M Sep/2025
Avanos Medical USD -1.2M 74.7M Sep/2025
Baxter International USD 121M 12M Sep/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Bio-Rad Laboratories USD 82.9M 331.1M Sep/2025
Boston Scientific USD 700M 238M Dec/2025
Cooper Companies USD 116.8M 137.4M Sep/2025
Danaher USD 1.24B 138M Mar/2026
Dentsply International USD -230M 77M Sep/2025
Dexcom USD 300M 58.9M Sep/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Globus Medical USD 143.99M 44.18M Sep/2025
Insulet USD 140.2M 17.4M Dec/2025
Integra LifeSciences USD -6.82M 524.13M Sep/2025
Intuitive Surgical USD 955.6M 100.4M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Masimo USD 74.9M 19.5M Sep/2025
Medtronic USD 2.1B 224M Sep/2025
Solventum Corp USD 511M 149M Sep/2025
Stryker USD 1.03B 13M Sep/2025
Tandem Diabetes Care USD -25.14M 32.58M Sep/2025
Teleflex USD -438.58M 573.82M Sep/2025
Terumo JPY 45.38B 578M Dec/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025